345 related articles for article (PubMed ID: 1563119)
21. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
Nissenson AR
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
[TBL] [Abstract][Full Text] [Related]
22. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
23. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
Salim KA; Salim S; Mathew T
J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463
[TBL] [Abstract][Full Text] [Related]
24. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
Barlogie B
Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
[TBL] [Abstract][Full Text] [Related]
25. Comparison of hemodialysis and peritoneal dialysis in the management of anemia related to chronic renal disease.
Korbet SM
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):9-15. PubMed ID: 2648520
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of multiple myeloma associated anemia with human recombinant erythropoietin in a hemodialysis patient].
Muszytowski M; Nowak J; Wojnicz M; Zalewska A; Ruszkiewicz-Fołda M
Pol Arch Med Wewn; 1995 Jan; 93(1):77-9. PubMed ID: 7479222
[TBL] [Abstract][Full Text] [Related]
27. Pediatric uses of recombinant human erythropoietin: the outlook in 1991.
Alexander SR
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):42-53. PubMed ID: 1928079
[TBL] [Abstract][Full Text] [Related]
28. Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment.
Adamson JW; Spivak JL
Surgery; 1994 Jan; 115(1):7-15. PubMed ID: 8284765
[TBL] [Abstract][Full Text] [Related]
29. r-HuEPO treatment of anemia associated with multiple myeloma and ESRD.
Van der Niepen P; Sennesael J; Verbeelen D
Clin Nephrol; 1993 Feb; 39(2):113. PubMed ID: 8448915
[No Abstract] [Full Text] [Related]
30. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
[No Abstract] [Full Text] [Related]
31. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
de Sousa FT; Prata MM; Barbas JV; dos Santos JP
Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
[TBL] [Abstract][Full Text] [Related]
32. Effect of recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic hemodialysis patients.
Huraib S; al-Momen AK; Gader AM; Mitwalli A; Sulimani F; Abu-Aisha H
Clin Nephrol; 1991 Nov; 36(5):252-7. PubMed ID: 1752076
[TBL] [Abstract][Full Text] [Related]
33. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
[TBL] [Abstract][Full Text] [Related]
34. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.
Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W
Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.
Desai JD; Shah BV
J Assoc Physicians India; 1991 Jun; 39(6):483-5. PubMed ID: 1938855
[No Abstract] [Full Text] [Related]
36. [Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma].
Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
Rinsho Ketsueki; 1993 Aug; 34(8):919-27. PubMed ID: 8411646
[TBL] [Abstract][Full Text] [Related]
37. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
39. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
[TBL] [Abstract][Full Text] [Related]
40. Continuous ambulatory peritoneal dialysis in end-stage renal disease due to multiple myeloma.
Shetty A; Oreopoulos DG
Perit Dial Int; 1995; 15(6):236-40. PubMed ID: 7578500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
